Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moll

Showing results (171-180 of 307) with videos related to

Pageof 31
Sort By:
Cytokine|July 4, 2021
Current status and relevance of single nucleotide polymorphisms in IL-6-/IL-12-type cytokine receptorsJürgen Scheller, Anna Berg, Jens M Moll, et al.
Annals of the Rheumatic Diseases|September 1, 1973
Walldius arthroplasty of the knee. Follow-up study of 51 operationsJ M Moll, P J Chesterman, R I Meanock, et al.
Molecular and Cellular Biology|July 16, 2004
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activationSusan Erster, Motohiro Mihara, Roger H Kim, et al.
Trends in Molecular Medicine|March 27, 2007
Classic and novel roles of p53: prospects for anticancer therapyJosé J Fuster, Silvia M Sanz-González, Ute M Moll, et al.
International Journal of Oncology|March 16, 2000
Lack of defective expression of the ATM gene in sporadic breast cancer tissues and cell linesS Kovalev, A Mateen, A I Zaika, et al.
Cell Death and Differentiation|October 28, 2017
Non-oncogenic roles of TAp73: from multiciliogenesis to metabolismAlice Nemajerova, Ivano Amelio, Jakob Gebel, et al.
Cell Death & Disease|April 26, 2020
Statin as anti-cancer therapy in autochthonous T-lymphomas expressing stabilized gain-of-function mutant p53 proteinsKaris Tutuska, Laura Parrilla-Monge, Erica Di Cesare, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 1998
Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosisM H Thelen, S M Eschmann, M Moll-Kotowski, et al.
Cell Death and Differentiation|March 21, 2009
The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteinsS Wolff, F Talos, G Palacios, et al.
Nature Reviews. Immunology|April 17, 2023
Targeting IL-6 trans-signalling: past, present and future prospectsStefan Rose-John, Brendan J Jenkins, Christoph Garbers, et al.
Pageof 31

Showing results (171-180 of 307) with videos related to

Sort By:
Pageof 31
Cytokine|July 4, 2021
Current status and relevance of single nucleotide polymorphisms in IL-6-/IL-12-type cytokine receptorsJürgen Scheller, Anna Berg, Jens M Moll, et al.
Annals of the Rheumatic Diseases|September 1, 1973
Walldius arthroplasty of the knee. Follow-up study of 51 operationsJ M Moll, P J Chesterman, R I Meanock, et al.
Molecular and Cellular Biology|July 16, 2004
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activationSusan Erster, Motohiro Mihara, Roger H Kim, et al.
Trends in Molecular Medicine|March 27, 2007
Classic and novel roles of p53: prospects for anticancer therapyJosé J Fuster, Silvia M Sanz-González, Ute M Moll, et al.
International Journal of Oncology|March 16, 2000
Lack of defective expression of the ATM gene in sporadic breast cancer tissues and cell linesS Kovalev, A Mateen, A I Zaika, et al.
Cell Death and Differentiation|October 28, 2017
Non-oncogenic roles of TAp73: from multiciliogenesis to metabolismAlice Nemajerova, Ivano Amelio, Jakob Gebel, et al.
Cell Death & Disease|April 26, 2020
Statin as anti-cancer therapy in autochthonous T-lymphomas expressing stabilized gain-of-function mutant p53 proteinsKaris Tutuska, Laura Parrilla-Monge, Erica Di Cesare, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 1998
Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosisM H Thelen, S M Eschmann, M Moll-Kotowski, et al.
Cell Death and Differentiation|March 21, 2009
The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteinsS Wolff, F Talos, G Palacios, et al.
Nature Reviews. Immunology|April 17, 2023
Targeting IL-6 trans-signalling: past, present and future prospectsStefan Rose-John, Brendan J Jenkins, Christoph Garbers, et al.
Pageof 31